PREDICT modeling and in-silico screening for G-protein coupled receptors

被引:90
作者
Shacham, S [1 ]
Marantz, Y [1 ]
Bar-Haim, S [1 ]
Kalid, O [1 ]
Warshaviak, D [1 ]
Avisar, N [1 ]
Inbal, B [1 ]
Heifetz, A [1 ]
Fichman, M [1 ]
Topf, M [1 ]
Naor, Z [1 ]
Noiman, S [1 ]
Becker, OM [1 ]
机构
[1] Predix Pharmaceut Ltd, IL-52521 Ramat Gan, Israel
关键词
modeling; docking; in silico screening; GPCR; structure based drug discovery;
D O I
10.1002/prot.20195
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
G-protein coupled receptors (GPCRs) are a major group of drug targets for which only one x-ray structure is known (the nondrugable rhodopsin), limiting the application of structure-based drug discovery to GPCRs. In this paper we present the details of PREDICT, a new algorithmic approach for modeling the 3D structure of GPCRs without relying on homology to rhodopsin. PREDICT, which focuses on the transmembrane domain of GPCRs, starts from the primary sequence of the receptor, simultaneously optimizing multiple 'decoy' conformations of the protein in order to find its most stable structure, culminating in a virtual receptor-ligand complex. In this paper we present a comprehensive analysis of three PREDICT models for the dopamine D2, neurokinin NK1, and neuropeptide Y Y1 receptors. A shorter discussion of the CCR3 receptor model is also included. All models were found to be in good agreement with a large body of experimental data. The quality of the PREDICT models, at least for drug discovery purposes, was evaluated by their successful utilization in in-silico screening. Virtual screening using all three PREDICT models yielded enrichment factors 9-fold to 44-fold better than random screening. Namely, the PREDICT models can be used to identify active small-molecule ligands embedded in large compound libraries with an efficiency comparable to that obtained using crystal structures for non-GPCR targets. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:51 / 86
页数:36
相关论文
共 187 条
[71]   Steric hindrance mutagenesis versus alanine scan in mapping of ligand binding sites in the tachykinin NK1 receptor [J].
Holst, B ;
Zoffmann, S ;
Elling, CE ;
Hjorth, SA ;
Schwartz, TW .
MOLECULAR PHARMACOLOGY, 1998, 53 (01) :166-175
[72]  
HONG Y, 1999, 217 ACS NAT M AN SPR
[73]   The local environment at the cytoplasmic end of TM6 of the μ opioid receptor differs from those of rhodopsin and monoamine receptors:: Introduction of an ionic lock between the cytoplasmic ends of helices 3 and 6 by a L6.30(275)E mutation inactivates the μ opioid receptor and reduces the constitutive activity of its T6.34(279)K mutant [J].
Huang, P ;
Visiers, I ;
Weinstein, H ;
Liu-Chen, LY .
BIOCHEMISTRY, 2002, 41 (40) :11972-11980
[74]   Functional role of a conserved motif in TM6 of the rat μ opioid receptor:: Constitutively active and inactive receptors result from substitutions of Thr6.34(279) with Lys and Asp [J].
Huang, P ;
Li, J ;
Chen, CG ;
Visiers, I ;
Weinstein, H ;
Liu-Chen, LY .
BIOCHEMISTRY, 2001, 40 (45) :13501-13509
[75]   DERIVATION OF CLASS-II FORCE-FIELDS .2. DERIVATION AND CHARACTERIZATION OF A CLASS-II FORCE-FIELD, CFF93, FOR THE ALKYL FUNCTIONAL-GROUP AND ALKANE MOLECULES [J].
HWANG, MJ ;
STOCKFISCH, TP ;
HAGLER, AT .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1994, 116 (06) :2515-2525
[76]   Axially chiral N-benzyl-N,7-dimethyl-5-phenyl-1,7-naphthyridine-6-carboxamide derivatives as tachykinin NK1 receptor antagonists:: Determination of the absolute stereochemical requirements [J].
Ikeura, Y ;
Ishichi, Y ;
Tanaka, T ;
Fujishima, A ;
Murabayashi, M ;
Kawada, M ;
Ishimaru, T ;
Kamo, I ;
Doi, T ;
Natsugari, H .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (22) :4232-4239
[77]   Residues in the fifth membrane-spanning segment of the dopamine D2 receptor exposed in the binding-site crevice [J].
Javitch, JA ;
Fu, DY ;
Chen, JY .
BIOCHEMISTRY, 1995, 34 (50) :16433-16439
[78]   A cluster of aromatic residues in the sixth membrane-spanning segment of the dopamine D2 receptor is accessible in the binding-site crevice [J].
Javitch, JA ;
Ballesteros, JA ;
Weinstein, H ;
Chen, JY .
BIOCHEMISTRY, 1998, 37 (04) :998-1006
[79]   A CYSTEINE RESIDUE IN THE 3RD MEMBRANE-SPANNING SEGMENT OF THE HUMAN D-2-DOPAMINE RECEPTOR IS EXPOSED IN THE BINDING-SITE CREVICE [J].
JAVITCH, JA ;
LI, XC ;
KABACK, J ;
KARLIN, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (22) :10355-10359
[80]   Comparative protein structure modeling by iterative alignment, model building and model assessment [J].
John, B ;
Sali, A .
NUCLEIC ACIDS RESEARCH, 2003, 31 (14) :3982-3992